Eric R. Rosenbaum
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Associate Professor of Pathology
Also affiliated: Arkansas Children's Hospital (2020–2025); University of Arkansas Medical Center (2024); Arkansas Department of Health (2020)
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Eric R. Rosenbaum's research interests include the clinical impact of diagnostic systems and the validation of predictive formulas in medical contexts. He has investigated the performance of the Accelerate Pheno Rapid Blood Culture Detection System in identifying bacteremic patients and has published on the validation of a formula for predicting daily CD34+ cell collection by leukapheresis. His work also extends to exploring potential transfusion-transmitted infections, as seen in his publication regarding a possible *Babesia divergens*-like/MO-1 infection. Rosenbaum’s scholarly contributions are reflected in his h-index of 15 and over 4,300 citations across 75 publications. His research activity is noted as recent.
Metrics
- h-index: 9
- Publications: 44
- Citations: 349
Positions
-
Associate Professor of Pathology publications 2009–2026University of Arkansas for Medical Sciences Institution web page
Selected Publications
-
Real-time Nanopore de novo assembly of ESKAPE pathogens: Implications for antibiotic stewardship (2026)
-
Progression of Sclerouveitis to Endogenous Fusarium Endophthalmitis (2024)
-
Treatment-emergent cefiderocol resistance in carbapenem-resistant Acinetobacter baumannii is associated with insertion sequence IS Aba36 in the siderophore receptor pirA (2024)
-
SARS-CoV-2 Infection Mitigation Strategies Concomitantly Reduce Group A Streptococcus Pharyngitis (2022)
-
Incidence of chorioretinitis and endophthalmitis in hospitalized patients with fungemia (2021)
-
Cutaneous Mycobacterium chelonae infection presenting clinically as a mycetoma (2021)
-
Real-World Impact of the Accelerate PhenoTest BC Kit on Patients With Bloodstream Infections in the Improving Outcomes and Antimicrobial Stewardship Study: A Quasiexperimental Multicenter Study (2021)
-
Improving outcomes and antibiotic stewardship (IOAS) for patients with Gram-positive bloodstream infections through use of rapid testing: a quasi-experimental multicentre study of the Accelerate PhenoTest™ BC Kit (2021)
-
Clinical Impact of Accelerate Pheno Rapid Blood Culture Detection System in Bacteremic Patients (2020)
-
Amoxicillin-Induced Crystalline Nephropathy Presenting as Ureteral Obstruction (2020)
-
2137. Impact of Accelerate Pheno™ Rapid Blood Culture Detection System with Real-time Notification vs. Standard Antibiotic Stewardship on Clinical Outcomes in Bacteremic Patients (2019)
-
487. Severity and Clinical Outcomes of Clostridium difficile Infection Based on Toxin B Assay Results (2018)
-
1758. Impact of Accelerate Pheno™ Rapid Blood Culture Detection System on Laboratory and Clinical Outcomes in Bacteremic Patients (2018)
-
An Enlarging Lung Nodule in an Immunocompromised Host (2017)
-
Percent cPRA (Calculated Panel Reactive Antibody) Value Predicts Percent of Positive Platelet Crossmatches. (2017)
Collaboration Network
Top Collaborators
- Validation of a formula for predicting daily CD34+ cell collection by leukapheresis
- Hematopoietic progenitor cell collection after autologous transplant for multiple myeloma: low platelet count predicts for poor collection and sole use of resulting graft enhances risk of myelodysplasia
- Analysis of CD34+ cell collection using two mobilization regimens for newly diagnosed multiple myeloma patients reveals the separate impact of mobilization and collection variables
- Rituximab and intermediate-purity plasma-derived factor VIII concentrate (Koate®) as adjuncts to therapeutic plasma exchange for thrombotic thrombocytopenic purpura in patients with an ADAMTS13 inhibitor
- Flow Cytometric Panel-Reactive Antibody Results and the Ability to Find Transfusion-Compatible Platelets after Antibody-Desensitization for Allogeneic Bone Marrow Transplant.
Showing 5 of 17 shared publications
- Hematopoietic progenitor cell collection after autologous transplant for multiple myeloma: low platelet count predicts for poor collection and sole use of resulting graft enhances risk of myelodysplasia
- Analysis of CD34+ cell collection using two mobilization regimens for newly diagnosed multiple myeloma patients reveals the separate impact of mobilization and collection variables
- A 15 Hour Dosing-Collection Interval for Plerixafor Is at Least as Effective as the Standard 10 Hour Interval.
- Validation of a Predictive Formula for Collection of Hematopoietic Progenitor Cells (HPC) By Leukapheresis at 2 Institutions Using 4 Different Machine Protocols
- Risk Of Myelodysplastic Syndrome (MDS) After Hematopoietic Progenitor Cell Collection Using Plerixafor
Showing 5 of 9 shared publications
- Clinical Impact of Accelerate Pheno Rapid Blood Culture Detection System in Bacteremic Patients
- Real-World Impact of the Accelerate PhenoTest BC Kit on Patients With Bloodstream Infections in the Improving Outcomes and Antimicrobial Stewardship Study: A Quasiexperimental Multicenter Study
- Treatment-emergent cefiderocol resistance in carbapenem-resistant Acinetobacter baumannii is associated with insertion sequence IS Aba36 in the siderophore receptor pirA
- Improving outcomes and antibiotic stewardship (IOAS) for patients with Gram-positive bloodstream infections through use of rapid testing: a quasi-experimental multicentre study of the Accelerate PhenoTest™ BC Kit
- 1758. Impact of Accelerate Pheno™ Rapid Blood Culture Detection System on Laboratory and Clinical Outcomes in Bacteremic Patients
Showing 5 of 7 shared publications
- Rituximab and intermediate-purity plasma-derived factor VIII concentrate (Koate®) as adjuncts to therapeutic plasma exchange for thrombotic thrombocytopenic purpura in patients with an ADAMTS13 inhibitor
- Flow Cytometric Panel-Reactive Antibody Results and the Ability to Find Transfusion-Compatible Platelets after Antibody-Desensitization for Allogeneic Bone Marrow Transplant.
- Percent cPRA (Calculated Panel Reactive Antibody) Value Predicts Percent of Positive Platelet Crossmatches.
- 183-P
- Percent cPRA (calculated Panel Reactive Antibody) Value Predicts Percent Positive Platelet Crossmatches
- Flow Cytometric Panel-Reactive Antibody Results and the Ability to Find Transfusion-Compatible Platelets after Antibody-Desensitization for Allogeneic Bone Marrow Transplant.
- Percent cPRA (Calculated Panel Reactive Antibody) Value Predicts Percent of Positive Platelet Crossmatches.
- 183-P
- Percent cPRA (calculated Panel Reactive Antibody) Value Predicts Percent Positive Platelet Crossmatches
- Analysis of CD34+ cell collection using two mobilization regimens for newly diagnosed multiple myeloma patients reveals the separate impact of mobilization and collection variables
- A Better Mobilization Regimen for Newly Diagnosed Multiple Myeloma Patients,
- Advanced Osteolytic Lesions (OL), Mobilization and Collection of Hematopoietic Progenitor Cells (HPC) in Multiple Myeloma (MM)
- Rituximab and intermediate-purity plasma-derived factor VIII concentrate (Koate®) as adjuncts to therapeutic plasma exchange for thrombotic thrombocytopenic purpura in patients with an ADAMTS13 inhibitor
- A 15 Hour Dosing-Collection Interval for Plerixafor Is at Least as Effective as the Standard 10 Hour Interval.
- Chemotherapy Does Not Enhance CD34+ Cell Collection When Added to Growth Factor and Plerixafor in Patients Who Are Poor Mobilizers
- Clinical Impact of Accelerate Pheno Rapid Blood Culture Detection System in Bacteremic Patients
- An Enlarging Lung Nodule in an Immunocompromised Host
- 487. Severity and Clinical Outcomes of Clostridium difficile Infection Based on Toxin B Assay Results
- An Enlarging Lung Nodule in an Immunocompromised Host
- 487. Severity and Clinical Outcomes of Clostridium difficile Infection Based on Toxin B Assay Results
- Real-time Nanopore de novo assembly of ESKAPE pathogens: Implications for antibiotic stewardship
- Clinical Impact of Accelerate Pheno Rapid Blood Culture Detection System in Bacteremic Patients
- 1758. Impact of Accelerate Pheno™ Rapid Blood Culture Detection System on Laboratory and Clinical Outcomes in Bacteremic Patients
- 2137. Impact of Accelerate Pheno™ Rapid Blood Culture Detection System with Real-time Notification vs. Standard Antibiotic Stewardship on Clinical Outcomes in Bacteremic Patients
- Clinical Impact of Accelerate Pheno Rapid Blood Culture Detection System in Bacteremic Patients
- 1758. Impact of Accelerate Pheno™ Rapid Blood Culture Detection System on Laboratory and Clinical Outcomes in Bacteremic Patients
- 2137. Impact of Accelerate Pheno™ Rapid Blood Culture Detection System with Real-time Notification vs. Standard Antibiotic Stewardship on Clinical Outcomes in Bacteremic Patients
- Clinical Impact of Accelerate Pheno Rapid Blood Culture Detection System in Bacteremic Patients
- 1758. Impact of Accelerate Pheno™ Rapid Blood Culture Detection System on Laboratory and Clinical Outcomes in Bacteremic Patients
- 2137. Impact of Accelerate Pheno™ Rapid Blood Culture Detection System with Real-time Notification vs. Standard Antibiotic Stewardship on Clinical Outcomes in Bacteremic Patients
- Clinical Impact of Accelerate Pheno Rapid Blood Culture Detection System in Bacteremic Patients
- 1758. Impact of Accelerate Pheno™ Rapid Blood Culture Detection System on Laboratory and Clinical Outcomes in Bacteremic Patients
- 2137. Impact of Accelerate Pheno™ Rapid Blood Culture Detection System with Real-time Notification vs. Standard Antibiotic Stewardship on Clinical Outcomes in Bacteremic Patients
- Hematopoietic progenitor cell collection after autologous transplant for multiple myeloma: low platelet count predicts for poor collection and sole use of resulting graft enhances risk of myelodysplasia
- Factors that predict successful remobilization after autologous hematopoietic progenitor cell transplant (aHCT) for multiple myeloma.
- Validation of a formula for predicting daily CD34+ cell collection by leukapheresis
- A Successful Model for Predicting CD34+ Cell Collection by Apheresis.
Similar Researchers
Based on overlapping research topics